Volume 22, Issue 10
Meet the Section Editor
Pp: 1577-1577
Author(s): Sergey Bachurin
DOI: 10.2174/1570159X2210240306123557
Abusive use of Zolpidem as a Result of COVID-19 and Perspectives of Continuity of the Problem in the Post-Pandemic Period
Pp: 1578-1582
Author(s): Wesley Dawison de Lima, Michael Douglas da Silva, Eurico de Souza Costa, Francisco Irochima Pinheiro, Eduardo Pereira de Azevedo, Ricardo Ney Cobucci, José Rodolfo Lopes de Paiva Cavalcanti and Fausto Pierdoná Guzen*
DOI: 10.2174/1570159X21666230920123401
Magnetic Resonance Imaging and Nuclear Imaging of Parkinsonian Disorders: Where do we go from here?
Pp: 1583-1605
Author(s): Félix-Antoine Savoie, David J. Arpin and David E. Vaillancourt*
DOI: 10.2174/1570159X21666230801140648
Future Directions for Developing Non-dopaminergic Strategies for the Treatment of Parkinson’s Disease
Pp: 1606-1620
Author(s): Daniel J. van Wamelen*, Valentina Leta, K. Ray Chaudhuri and Peter Jenner
DOI: 10.2174/1570159X21666230731110709
Naturally Occurring Cholinesterase Inhibitors from Plants, Fungi, Algae, and Animals: A Review of the Most Effective Inhibitors Reported in 2012-2022
Pp: 1621-1649
Author(s): Ana Paula Murray*, Brunella Biscussi, Valeria Cavallaro, Martina Donozo and Silvana A. Rodriguez
DOI: 10.2174/1570159X21666230623105929
Insights Into the Role of Copper in Neurodegenerative Diseases and the Therapeutic Potential of Natural Compounds
Pp: 1650-1671
Author(s): Guangcheng Zhong, Xinyue Wang, Jiaqi Li, Zhouyuan Xie, Qiqing Wu, Jiaxin Chen, Yiyun Wang, Ziying Chen, Xinyue Cao, Tianyao Li, Jinman Liu* and Qi Wang*
DOI: 10.2174/1570159X22666231103085859
Metabolic Reprogramming in Gliocyte Post-cerebral Ischemia/ Reperfusion: From Pathophysiology to Therapeutic Potential
Pp: 1672-1696
Author(s): Lipeng Gong, Junjie Liang, Letian Xie, Zhanwei Zhang*, Zhigang Mei* and Wenli Zhang*
DOI: 10.2174/1570159X22666240131121032
Hair Cortisol Research in Posttraumatic Stress Disorder - 10 Years of Insights and Open Questions. A Systematic Review
Pp: 1697-1719
Author(s): Lena Schindler-Gmelch, Klara Capito, Susann Steudte-Schmiedgen*, Clemens Kirschbaum and Matthias Berking
DOI: 10.2174/1570159X21666230807112425
Bibliometric Analysis of the Research Status and Global Trends in Behavioral and Psychological Symptoms of Dementia in Alzheimer’s Disease from 2002 to 2022
Pp: 1720-1732
Author(s): Haipeng Cai, Ruonan Du, Kebing Yang, Wei Li and Zhiren Wang*
DOI: 10.2174/1570159X21666230807144750
Smoking, Symptoms Improvement, and Total Antioxidant Capacity in Patients with Drug-naive First-episode Schizophrenia: A Prospective Cohort Study
Pp: 1733-1741
Author(s): Zhiyong Gao, Meihong Xiu, Jiahong Liu, Fengchun Wu* and Xiangyang Zhang*
DOI: 10.2174/1570159X22666231019105328
Cariprazine Augmentation in Treatment-Resistant Bipolar Depression: Data from a Retrospective Observational Study
Pp: 1742-1748
Author(s): Elena Teobaldi, Enrico Pessina, Azzurra Martini, Carlo Ignazio Cattaneo, Domenico De Berardis, Vassilis Martiadis, Giuseppe Maina* and Gianluca Rosso
DOI: 10.2174/1570159X22666240129095852
Modulating Mitochondrial Dynamics Mitigates Cognitive Impairment in Rats with Myocardial Infarction
Pp: 1749-1760
Author(s): Kewarin Jinawong, Chanon Piamsiri, Nattayaporn Apaijai, Chayodom Maneechote, Busarin Arunsak, Wichwara Nawara, Chanisa Thonusin, Hiranya Pintana, Nipon Chattipakorn and Siriporn C. Chattipakorn*
DOI: 10.2174/1570159X22666240131114913